180 related articles for article (PubMed ID: 26375248)
1. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients.
Chen M; Zeng Z; Li X; Qin W; Cai X; Chen S; Lu X
Int J Lab Hematol; 2023 Dec; 45(6):899-907. PubMed ID: 37519024
[TBL] [Abstract][Full Text] [Related]
3. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Whitman SP; Liu S; Vukosavljevic T; Rush LJ; Yu L; Liu C; Klisovic MI; Maharry K; Guimond M; Strout MP; Becknell B; Dorrance A; Klisovic RB; Plass C; Bloomfield CD; Marcucci G; Caligiuri MA
Blood; 2005 Jul; 106(1):345-52. PubMed ID: 15774615
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and prognosis of
Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Zarnegar-Lumley S; Alonzo TA; Gerbing RB; Othus M; Sun Z; Ries RE; Wang J; Leonti A; Kutny MA; Ostronoff F; Radich JP; Appelbaum FR; Pogosova-Agadjanyan EL; O'Dwyer K; Tallman MS; Litzow M; Atallah E; Cooper TM; Aplenc RA; Abdel-Wahab O; Gamis AS; Luger S; Erba H; Levine R; Kolb EA; Stirewalt DL; Meshinchi S; Tarlock K
Blood Adv; 2023 Oct; 7(19):5941-5953. PubMed ID: 37267439
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.
Yuan XQ; Zhang DY; Yan H; Yang YL; Zhu KW; Chen YH; Li X; Yin JY; Li XL; Zeng H; Chen XP
Oncotarget; 2016 Sep; 7(37):60555-60574. PubMed ID: 27528035
[TBL] [Abstract][Full Text] [Related]
7. Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience.
Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of fusion gene expression in acute myeloid leukemia].
Yan Q; Lin YN; Huang XQ; Qian LZ; Ma JT; Zhang H; Chen L; Chen XJ; Mi YC; Ru K
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):480-486. PubMed ID: 34384154
[No Abstract] [Full Text] [Related]
9. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
[TBL] [Abstract][Full Text] [Related]
10. Identification of Cell Type-Specific Effects of
Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of
Lin ME; Hou HA; Tsai CH; Wu SJ; Kuo YY; Tseng MH; Liu MC; Liu CW; Chou WC; Chen CY; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Lin CT; Tien HF
Clin Epigenetics; 2018; 10():42. PubMed ID: 29619119
[TBL] [Abstract][Full Text] [Related]
12. Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia.
Alqahtani A; Wang M; Lou M; Alachkar H
Clin Transl Sci; 2023 Oct; 16(10):1828-1841. PubMed ID: 37670476
[TBL] [Abstract][Full Text] [Related]
13. Demethylator phenotypes in acute myeloid leukemia.
Kelly AD; Madzo J; Madireddi P; Kropf P; Good CR; Jelinek J; Issa JJ
Leukemia; 2018 Oct; 32(10):2178-2188. PubMed ID: 29556023
[TBL] [Abstract][Full Text] [Related]
14. Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia.
Bhatnagar B; Kohlschmidt J; Mrózek K; Zhao Q; Fisher JL; Nicolet D; Walker CJ; Mims AS; Oakes C; Giacopelli B; Orwick S; Boateng I; Blachly JS; Maharry SE; Carroll AJ; Powell BL; Kolitz JE; Stone RM; Byrd JC; Paskett ED; de la Chapelle A; Garzon R; Eisfeld AK
Cancer Discov; 2021 Mar; 11(3):626-637. PubMed ID: 33277314
[TBL] [Abstract][Full Text] [Related]
15. Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway.
Palam LR; Ramdas B; Pickerell K; Pasupuleti SK; Kanumuri R; Cesarano A; Szymanski M; Selman B; Dave UP; Sandusky G; Perna F; Paczesny S; Kapur R
JCI Insight; 2023 May; 8(9):. PubMed ID: 36976647
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the clinical characteristics and prognosis of adult
Sheng L; Liu Y; Zhu Y; Zhou J; Hua H
Open Med (Wars); 2023; 18(1):20230830. PubMed ID: 38025540
[TBL] [Abstract][Full Text] [Related]
17. RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.
Andrade FG; Furtado-Silva JM; Gonçalves BA; Thuler LC; Barbosa TC; Emerenciano M; Siqueira A; Pombo-de-Oliveira MS;
BMC Cancer; 2014 Feb; 14():133. PubMed ID: 24571676
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of
Qiu KY; Liao XY; Huang K; Xu HG; Li Y; Zhou DH; Fang JP
Transl Cancer Res; 2023 Oct; 12(10):2952-2958. PubMed ID: 37969368
[TBL] [Abstract][Full Text] [Related]
19. Genomic Characterization of Partial Tandem Duplication Involving the
Seto A; Downs G; King O; Salehi-Rad S; Baptista A; Chin K; Grenier S; Nwachukwu B; Tierens A; Minden MD; Smith AC; Capo-Chichi JM
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730645
[TBL] [Abstract][Full Text] [Related]
20. SFXN3 is Associated with Poor Clinical Outcomes and Sensitivity to the Hypomethylating Therapy in Non-M3 Acute Myeloid Leukemia Patients.
Dong Y; Jin F; Wang J; Li Q; Huang Z; Xia L; Yang M
Curr Gene Ther; 2023; 23(5):410-418. PubMed ID: 37491851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
